📌Happy to share our perspective on uveal melanoma management, just out in @ESMO_Open
With this amazing team @mauriciofribei1@IanHirsch3
🔗 https://t.co/6mdjaLy7s8
1/
Large Language Models (LLMs) contain extensive medical knowledge despite not being specifically trained for it; but, their performance on standardized tests across various subspecialties is inconsistent.
5/
Overall, our findings suggest LLMs hold promise for enhancing healthcare, but they require rigorous testing and oversight to ensure safety. The future of AI in medicine is bright but must be navigated with caution.
1/
Palliative care (PC) can significantly improve outcomes for advanced cancer patients. But limited capacity often delays or prevents access. Our latest study from Ontario, 🇨🇦, explores using machine learning to address this gap. @JCO_ASCO https://t.co/QdUL99f5lo
New paper out in @JCO_ASCO!
Fantastic effort by Kevin and the team.
Using @ICESOntario data, we show how machine learning could benefit patients through early palliative care.
Thanks to @thePMCF and @OICR_news for their support!
https://t.co/5t8AkbPFZ9
Argentina currently spends just 0.5% of its GDP on R&D, which is low even by the standards of some middle-income countries . That is what Argentina should aspire to. The nation’s leaders need to work closely with scientists and tap into their knowledge and skills.
Cutting health and science support should not be an option in Argentina’s election.
As the nation chooses its next president, citizens must consider the wider benefits of research investment — long-term prosperity, well-being and growth https://t.co/IKWEHUwFfZ
En este momento quedarse callado es ser cómplice.
La ultraderecha aplasta minorías y nos niega como individuos en pos de un plan económico que beneficia a un sector reducido de la sociedad.
Entiendo la bronca por la situación de Argentina pero Milei NO es la salida.